These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 21090835)

  • 21. Pharmacotherapy of bipolar depression: an update.
    Thase ME
    Curr Psychiatry Rep; 2006 Dec; 8(6):478-88. PubMed ID: 17094928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.
    Atkin T; Nuñez N; Gobbi G
    J Child Psychol Psychiatry; 2017 Aug; 58(8):865-879. PubMed ID: 28474733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of depressive and bipolar disorder patients with mixed features.
    Tondo L; Vázquez GH; Pinna M; Vaccotto PA; Baldessarini RJ
    Acta Psychiatr Scand; 2018 Sep; 138(3):243-252. PubMed ID: 29862493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bipolar disorder, not so rare diagnosis: subtypes of different degrees of severity, diagnosis, therapy.
    Amihăesei IC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):111-5. PubMed ID: 24741786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode.
    Correll CU; Hauser M; Penzner JB; Auther AM; Kafantaris V; Saito E; Olvet D; Carrión RE; Birmaher B; Chang KD; DelBello MP; Singh MK; Pavuluri M; Cornblatt BA
    Bipolar Disord; 2014 Aug; 16(5):478-92. PubMed ID: 24597782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5-12.
    Wozniak J; Farrell A; DiSalvo M; Ceranoglu A; Uchida M; Vaudreuil C; Joshi G; Faraone SV; Cook E; Biederman J
    Psychopharmacol Bull; 2022 Oct; 52(4):31-51. PubMed ID: 36339275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological interventions for bipolar youth: developmental considerations.
    DelBello MP; Kowatch RA
    Dev Psychopathol; 2006; 18(4):1231-46. PubMed ID: 17064436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker.
    McNamara RK; Jandacek R; Tso P; Blom TJ; Welge JA; Strawn JR; Adler CM; Strakowski SM; DelBello MP
    Early Interv Psychiatry; 2016 Jun; 10(3):203-11. PubMed ID: 26486098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 fatty acids for bipolar disorder.
    Montgomery P; Richardson AJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005169. PubMed ID: 18425912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    Sachs GS; Nierenberg AA; Calabrese JR; Marangell LB; Wisniewski SR; Gyulai L; Friedman ES; Bowden CL; Fossey MD; Ostacher MJ; Ketter TA; Patel J; Hauser P; Rapport D; Martinez JM; Allen MH; Miklowitz DJ; Otto MW; Dennehy EB; Thase ME
    N Engl J Med; 2007 Apr; 356(17):1711-22. PubMed ID: 17392295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological treatment of bipolar disorder in children and adolescents].
    Bailly D
    Encephale; 2017 May; 43(3):254-258. PubMed ID: 27198073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype.
    Geller B; Craney JL; Bolhofner K; Nickelsburg MJ; Williams M; Zimerman B
    Am J Psychiatry; 2002 Jun; 159(6):927-33. PubMed ID: 12042179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?
    Goodwin FK; Whitham EA; Ghaemi SN
    CNS Drugs; 2011 Oct; 25(10):819-27. PubMed ID: 21936585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bipolar disorders: a review.
    Price AL; Marzani-Nissen GR
    Am Fam Physician; 2012 Mar; 85(5):483-93. PubMed ID: 22534227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Child and adolescent bipolar disorder].
    Aichhorn W; Stuppäck C; Kralovec K; Yazdi K; Aichhorn M; Hausmann A
    Neuropsychiatr; 2007; 21(2):84-92. PubMed ID: 17640494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prepubertal bipolar disorder: available pharmacological treatment options.
    Masi G
    Expert Opin Pharmacother; 2005 Apr; 6(4):547-60. PubMed ID: 15934881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.